Search
for
Sort by
Research 571–600 of 1000+
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- Scalp Involvement in Primary Cutaneous Lymphomas—An Update on Clinical Presentation, Diagnostics, and Management
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- Case report: Systemic granulomatous disease with vasculitis in a bull due to hairy vetch (Vicia villosa) toxicosis
- Rare and misdiagnosed entity fibrosing alopecia in a pattern distribution: A case report
- Alymphoid cystic thymic dysgenesis - FOXN1 gene mutation: a rare case report of two siblings
- Roles of the Hedgehog Signaling Pathway in Cutaneous Physiology and Oncology
- Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)
- Compound Heterozygous Mutations in <i>Forkhead Box N1</i> (<i>FOXN1</i>) Lead to a Severe Immunodeficiency but Normal Hair and Nail Development in Patients
- Research Snippets
- Skin manifestations of celiac disease
- Alopecia areata: Pathogenesis and treatment
- Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata
- miR‐218‐5p regulates skin and hair follicle development through Wnt/β‐catenin signaling pathway by targeting SFRP2
- Decreased lymphocyte reactivity and auto-immunity in alopecia areata
- Alefacept for Severe Alopecia Areata
- Current and Potential Agents for the Treatment of Alopecia Areata>
- Hyperplasia of Hair Follicles and Other Adnexal Structures in Cutaneous Lymphoproliferative Disorders
- Localized syringolymphoid hyperplasia with alopecia and anhidrosis
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Hair Growth on Nude Mice Due to Cyclosporin A
- Alopecia areata
- Clinical observations in alopecia areata: Implications and hypotheses
- Solitary fixed drug eruption caused by finasteride
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- Regulation of immune response genes in the skin of allergic and clinically tolerant individuals exposed to p‐phenylenediamine